We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.74B
1-Year Est. Return 34.09%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+34.09%
3 Year Est. Return
+68.11%
5 Year Est. Return
+74.85%
10 Year Est. Return
+251.8%
AUM
$1.19B
AUM Growth
+$184M
Cap. Flow
+$103M
Cap. Flow %
8.72%
Top 10 Hldgs %
36.02%
Holding
360
New
23
Increased
72
Reduced
151
Closed
16

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.33%
2 Technology 16.61%
3 Consumer Discretionary 9.03%
4 Financials 8.99%
5 Healthcare 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
51
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.3B
$5.68M 0.48%
75,516
+22,984
+44% +$1.72M
MET icon
52
MetLife
MET
$61.8B
$5.6M 0.47%
77,372
-557
-0.7% -$39.9K
JNJ icon
53
Johnson & Johnson
JNJ
$644B
$5.54M 0.47%
31,352
-1,662
-5% -$287K
AON icon
54
Aon
AON
$63.8B
$5.4M 0.46%
18,000
IEMG icon
55
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$4.93M 0.42%
+105,533
New +$4.8M
PEP icon
56
PepsiCo
PEP
$183B
$4.8M 0.41%
26,579
+677
+3% +$121K
PFE icon
57
Pfizer
PFE
$157B
$4.1M 0.35%
80,061
-4,869
-6% -$233K
DIS icon
58
Walt Disney
DIS
$185B
$4M 0.34%
46,038
-2,528
-5% -$242K
CRM icon
59
Salesforce
CRM
$206B
$3.84M 0.32%
28,937
-1,242
-4% -$181K
GIS icon
60
General Mills
GIS
$19.7B
$3.57M 0.3%
42,635
-924
-2% -$75.3K
EL icon
61
Estee Lauder
EL
$34.6B
$3.41M 0.29%
13,742
-134
-1% -$29.9K
ATVI
62
DELISTED
Activision Blizzard
ATVI
$3.34M 0.28%
43,651
-691
-2% -$51.3K
CVX icon
63
Chevron
CVX
$415B
$3.22M 0.27%
17,953
-123
-0.7% -$21.5K
GEM icon
64
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
$3.19M 0.27%
112,663
-22,330
-17% -$612K
PDCE
65
DELISTED
PDC Energy, Inc.
PDCE
$3.16M 0.27%
49,838
-1,800
-3% -$126K
BSCO
66
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$3.01M 0.25%
147,097
-14,054
-9% -$287K
USMV icon
67
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
$2.91M 0.25%
40,294
-950
-2% -$67.6K
IEFA icon
68
iShares Core MSCI EAFE ETF
IEFA
$192B
$2.72M 0.23%
44,184
+12,054
+38% +$709K
J icon
69
Jacobs Solutions
J
$16.8B
$2.54M 0.21%
25,543
-264
-1% -$25.9K
JJSF icon
70
J&J Snack Foods
JJSF
$1.51B
$2.52M 0.21%
16,825
-35
-0.2% -$5.19K
ECL icon
71
Ecolab
ECL
$76.8B
$2.45M 0.21%
+16,810
New +$2.47M
MMM icon
72
3M
MMM
$83.9B
$2.44M 0.21%
24,349
-3,842
-14% -$392K
MRK icon
73
Merck
MRK
$358B
$2.42M 0.2%
21,769
+259
+1% +$26.5K
VBR icon
74
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.3B
$2.38M 0.2%
14,970
+2,453
+20% +$391K
WEN icon
75
Wendy's
WEN
$1.34B
$2.25M 0.19%
99,381
-250
-0.3% -$5.34K

Similar funds

Shufro Rose & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Shufro Rose & Co held 360 positions worth $1.19B, up 18% from $1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Shufro Rose & Co deployed $103M of net new capital in Q4 2022, opening 23 new positions and adding to 72 existing holdings. Its largest new stake was iShares iBonds Dec 2023 Term Treasury ETF: 2,784,203 shares worth $68.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $63.5M trimmed.

  • Shufro Rose & Co's largest Q4 2022 buy was iShares iBonds Dec 2023 Term Treasury ETF: 2,784,203 shares worth $68.8M.
  • Shufro Rose & Co added most to Invesco BulletShares 2026 Corporate Bond ETF in Q4 2022, an estimated $63.7M increase.
  • Shufro Rose & Co's biggest Q4 2022 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $63.5M.
  • Shufro Rose & Co fully exited Goldman Sachs Equal Weight US Large Cap Equity ETF in Q4 2022, selling an estimated $9.02M.
  • Shufro Rose & Co's ten largest holdings make up 36% of its $1.19B portfolio in Q4 2022.
  • Shufro Rose & Co opened 23 new positions and closed 16 in Q4 2022.
  • Shufro Rose & Co's portfolio value rose 18% quarter-over-quarter to $1.19B.

Based on Shufro Rose & Co's 13F filing for Q4 2022, filed 25 Jan 2023.